@nkf profile picture
National Kidney Foundation @nkf

We’re fighting to eliminate preventable kidney disease, accelerate innovation, and dismantle structural inequities in kidney care. Join our fight.

Joined July 2007
  • Tweets 19,408
  • Following 892
  • Followers 44,159
3,710 Photos and videos
If you know someone living with immunoglobulin A nephropathy (IgAN), or Berger’s disease, this clinical research study may be an option. Learn more: bit.ly/4oN0ojP
5
949
If you know someone living with immunoglobulin A nephropathy (IgAN), or Berger’s disease, this clinical research study may be an option. Learn more: bit.ly/4oN0ojP
1
4
1,144
This clinical research study is evaluating an investigational treatment option to potentially help manage and slow the progression of immunoglobulin A nephropathy (IgAN), or Berger’s disease. Learn more: bit.ly/4oN0ojP
7
4
1,152
Patients living with Immunoglobulin A nephropathy (IgAN), or Berger’s disease, may be eligible for a clinical research study that may help improve kidney function and slow the progression of IgAN. Learn more: bit.ly/3H23xMj
3
3
6
1,485
Join us virtually as we highlight real-world implementation data from NKF’s flagship CKDintercept program, a national strategy to improve CKD testing, diagnosis, and management in the primary care setting. RSVP: bit.ly/4niApQz
3
12
1,247
Today is #C3GAwarenessDay! C3G is a rare kidney disease with a lifelong impact. Explore our resources for understanding, diagnosing, and treating C3G. kidney.org/kidney-topics/com…

Complement 3 Glomerulopathy (C3G)

C3G, or complement 3 glomerulopathy, is a rare kidney disease with a lifelong impact.

kidney.org
3
4
9
1,403
Patients with kidney disease deserve more than outdated technology and limited options. Let’s create better treatments and better outcomes. support.kidney.org/campaign/…

Donate to National Kidney Foundation

Kidney patients deserve better: https://support.kidney.org/campaign/612763/donate

support.kidney.org
6
6
16
1,675
We are one community united by a shared belief in the lifesaving power of our collective steps. Will you contribute to our goal by walking with us? KidneyWalk.org #KidneyWalk
3
6
11
1,388
Jessika and Joey didn’t let kidney failure stop them from falling in love or planning a wedding at the Kidney Walk. Here’s how their NKF community helped make it happen. kidney.org/news-stories/he-p…

He Proposed at NKF’s Kidney Walk. Now He Hopes to Save Her Life with a Kidney Donation

Their engagement made headlines. Now they’re hoping he’ll be the match she needs to leave dialysis behind.

kidney.org
13
1,136
National Kidney Foundation retweeted
NKF Advocacy@NKF_Advocacy
19 Aug 2025
TODAY is Kidney Heroes Giving Day! Today we honor KIDNEY HEROES and the life-changing difference they make for people with kidney disease. From donors and recipients to doctors and family members, anyone can be a kidney hero. Honor your hero: bit.ly/44W83Wq
2
3
9
985
When Patrick experienced sudden foot pain, he never imagined it would lead to a diagnosis of IgA nephropathy, or IgAN, a serious form of chronic kidney disease. kidney.org/news-stories/10-y…

10 Years on Dialysis: Overcoming IgA Nephropathy and Finding Purpose

Learn how Patrick faced 10 years of dialysis for IgA nephropathy, received a transplant, and now inspires other kidney patients to find hope and purpose.

kidney.org
1
6
996
Currently, there aren’t enough donated kidneys to meet the growing demand. But xenotransplantation could help change that. kidney.org/news-stories/clin…

Clinical Trials for Pig-to-Human Kidney Transplantation Are Here

This year, one of the most groundbreaking developments in kidney care is finally becoming reality: The FDA approved the first clinical trials for kidney xenotransplantation in the U.S. This moment...

kidney.org
1
4
11
974
If you know someone living with immunoglobulin A nephropathy (IgAN), or Berger’s disease, this clinical research study may be an option. Learn more: bit.ly/3H23xMj
2
857
Tell your legislator to support programs that work to increase early detection, improve outcomes, address health disparities, and develop innovative treatments for kidney patients. bit.ly/4bP557V
2
4
11
1,344
This clinical research study is evaluating an investigational treatment option to potentially help manage and slow the progression of immunoglobulin A nephropathy (IgAN), or Berger’s disease. Learn more: bit.ly/3H23xMj
2
2
5
1,194
RESET-SLE™ is a phase 1/2 clinical trial being conducted to evaluate the effects of an investigational cell therapy, CABA-201, in patients with active lupus nephritis (LN) or active lupus (SLE) without renal involvement. Learn more about the study at reset-sle-trial.com.
2
812
The RAINIER Study aims to reach higher summits in IgAN research. Learn more: bit.ly/4kffEF2
1
2
940
Today is #KidneyCancerAwarenessDay! Do you know the facts about kidney cancer? Watch our short animated videos to learn more. bit.ly/3j1YGgr

2
4
12
1,924
Today is #FSGS Awareness Day! The New Era Act helps patients with rare kidney diseases by promoting early detection of rare and genetic kidney diseases, enhancing education of doctors and patients, and conducting more research. We need YOUR voice to push it across the finish line. bit.ly/3TdcYvh
2
2
8
1,320
Patients living with Immunoglobulin A nephropathy (IgAN), or Berger’s disease, may be eligible for a clinical research study that may help improve kidney function and slow the progression of IgAN. Learn more: bit.ly/3H23xMj
1
3
6
1,161
Load more